KIT and platelet-derived growth factor receptor-β mutations are demonstrated in the overwhelming majority of adults with GIST, and approximately 80% of adult patients have KIT gene mutations that leads to constitutive activation of the KIT receptor [19]. This evidence concerns the gene KIT and gastrointestinal stromal tumor.